FDA approves generic Trileptal

WASHINGTON The Food and Drug Administration has approved the first generic versions of Trileptal, an anticonvulsant drug.

Trileptal is prescribed to be either used alone or in combination with other medications in the treatment of partial seizures in adults and children aged four years and above. The generic, oxcarbazepine will be available in three strengths: 150 mg, 300 mg, and 600 mg.

Roxane Laboratories, Glenmark Pharmaceuticals, and Sun Pharmaceutical Industries will manufacture Oxcarbazepine. Trileptal was the 74th best selling brand-name drug in the U.S. in 2006, according to Drug Topics.